Gliadel Implant 7.7Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Gliadel: Implant (7.7mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CARMUSTINE, BCNU (kar MUS teen) is a chemotherapy drug. It is used to treat glioma and glioblastoma. The wafers are placed at a site where a brain tumor used to be, at the end of a surgery to remove the tumor.

In-Depth Information
Select a Medication

Gliadel 7.7mg Wafer

NDC: 580630100
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Medulloblastoma, Malignant Glioma, Brain Metastases, Astrocytoma

Storage Information
Store frozen product at or below -4 degrees F
Gliadel 7.7mg Wafer

Reported Side Effects for Gliadel 7.7mg Wafer

Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Bleeding In The Brain Incidence:
<6.0%*
Severity: SEVERE
Onset: DELAYED
Fecal Incontinence Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Difficulty Swallowing Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
1.0-18.0%*
Severity: MILD
Onset: DELAYED
High White Blood Cells Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Double Vision Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
1.0-22.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Coma Incidence:
1.0-4.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
1.0-7.0%*
Severity: MILD
Onset: DELAYED
Paranoia Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
1.0%*
Severity: MODERATE
Onset: RAPID
Eye Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
2.0-12.0%*
Severity: MILD
Onset: EARLY
Incoordination Incidence:
2.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
2.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
2.0-19.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
3.0-16.0%*
Severity: MODERATE
Onset: DELAYED
High Pressure In Brain Incidence:
4.0-9.0%*
Severity: SEVERE
Onset: EARLY
Brain Infection Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Of The Brain Incidence:
4.0-23.0%*
Severity: SEVERE
Onset: EARLY
Hallucinations Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Veno-occlusive Disease (VOD) Incidence:
5.0-20.0%*
Severity: SEVERE
Onset: DELAYED
Sinusoidal Obstruction Syndrome (SOS) Incidence:
5.0-20.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Of The Brain Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Diabetes Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Bleeding Incidence:
7.0%*
Severity: MODERATE
Onset: EARLY
Muscle Paralysis Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Nervousness Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
8.0-21.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
8.0-22.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
10.0-23.0%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
12.0-18.0%*
Severity: MILD
Onset: EARLY
Decreased Healing Incidence:
14.0-15.8%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
15.0-28.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
19.0-37.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Gliadel

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5